<DOC>
	<DOC>NCT02699060</DOC>
	<brief_summary>This study is proposed to evaluate the role of motoric dysfunctions and burden of different kinds of refluxate on immune cells and the subsequent course of the disease. This study also aims to establish a bridge between instrumental findings (pH-impedance test) and clinical assessments (FSSG questionnaire), aiming to facilitate the use of simple questionnaire techniques in the clinical setting in the future.</brief_summary>
	<brief_title>Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Plasticity and Its Correlation With Different Forms of Gastroesophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<criteria>Clinical (patients) part 1. Signed informed consent 2. Gender: Male or Female 3. Age: 1865 years of age 3. Clinically and/or endoscopically confirmed diagnosis of GERD Clinical: (patient) 1. Current treatment with proton pump inhibitors and/or histamine2 receptor antagonists. These treatments should have been stopped at least 1 week prior to study inclusion. 2. Female patients who are pregnant, planning to become pregnant or lactating 3. Any acute diseases or conditions, exacerbations of concomitant chronic diseases (including but not limited to inflammatory bowel disease (IBD), ulcer disease etc.) at study start/inclusion and/or which are not resolved 14 days prior to studyenrolment. 4. Participation in a clinical trial in the past 3 months 5. Any condition which, in the opinion of investigator, makes the patient unsuitable for participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>GERD</keyword>
	<keyword>Barrett`s esophagus</keyword>
	<keyword>macrophage</keyword>
	<keyword>FSSG questionnaire</keyword>
</DOC>